Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Capital Bancorp, Inc.
50.1% sales growth and 15.3% return on equity
Capital Bancorp, Inc. operates as the bank holding company for Capital Bank, N.A. that provides various commercial banking products and services to businesses, not-for-profit associations, and entrepreneurs in the United States.
Capital Bancorp, Inc.'s sales growth this year is expected to be 52.1% and 5.3% for next year.
Year-on-year quarterly revenue growth grew by 63.1%, now sitting on 115.18M for the twelve trailing months.
Capital Bancorp, Inc.'s sales growth for the next quarter is 50.1%. The company's growth estimates for the current quarter and the next is 52.8% and 85.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.3%.
Volatility
Capital Bancorp, Inc.'s last day, last week, and last month's average volatility was 0.29%, 0.37%, and 0.75%, respectively.
Capital Bancorp, Inc.'s last day, last week, and last month's high and low average amplitude percentage was 1.15%, 3.17%, and 3.48%, respectively.
Capital Bancorp, Inc.'s Stock Yearly Top and Bottom Value
Capital Bancorp, Inc.'s stock is valued at $13.93 at 19:22 EST, under its 52-week high of $14.97 and way above its 52-week low of $6.98.
Capital Bancorp, Inc.'s Moving Average
Capital Bancorp, Inc.'s value is higher than its 50-day moving average of $12.73 and way higher than its 200-day moving average of $10.98.2. BOK Financial Corporation
6.9% sales growth and 7.77% return on equity
BOK Financial Corporation operates as the financial holding company for BOKF, NA that provides various financial products and services in Oklahoma, Texas, New Mexico, Northwest Arkansas, Colorado, Arizona, and Kansas/Missouri.
BOK Financial Corporation's sales growth this year is expected to be 10.1% and a negative 3.3% for next year.
Year-on-year quarterly revenue growth grew by 11.5%, now sitting on 1.66B for the twelve trailing months.
BOK Financial Corporation's sales growth for the next quarter is 6.9%. The company's growth estimates for the current quarter and the next is 22.4% and 103.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.77%.
Volatility
BOK Financial Corporation's last day, last week, and last month's average volatility was a negative 0.76%, a negative 0.28%, and a negative 0.01%, respectively.
BOK Financial Corporation's last day, last week, and last month's high and low average amplitude percentage was 2.10%, 2.48%, and 2.47%, respectively.
BOK Financial Corporation's Stock Yearly Top and Bottom Value
BOK Financial Corporation's stock is valued at $68.48 at 19:22 EST, way under its 52-week high of $87.97 and way higher than its 52-week low of $34.57.
BOK Financial Corporation's Moving Average
BOK Financial Corporation's value is below its 50-day moving average of $69.44 and way higher than its 200-day moving average of $59.50.3. Genmab A/S
51.6% sales growth and 36.46% return on equity
Genmab A/S, a biotechnology company, develops antibody therapeutics for the treatment of cancer primarily in Denmark.
Genmab A/S's sales growth this year is expected to be 101.8% and a negative 20.4% for next year.
Year-on-year quarterly revenue growth grew by 65.8%, now sitting on N/A for the twelve trailing months.
Genmab A/S's sales growth for the next quarter is 51.6%. The company's growth estimates for the current quarter and the next is a negative 65.7% and 30%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 36.46%.
Volatility
Genmab A/S's last day, last week, and last month's average volatility was a positive 0.05%, a negative 0.67%, and a positive 0.51%, respectively.
Genmab A/S's last day, last week, and last month's high and low average amplitude percentage was 0.87%, 1.25%, and 1.51%, respectively.
Genmab A/S's Stock Yearly Top and Bottom Value
Genmab A/S's stock is valued at $39.11 at 19:22 EST, under its 52-week high of $40.60 and way above its 52-week low of $16.24.
Genmab A/S's Moving Average
Genmab A/S's worth is above its 50-day moving average of $37.92 and above its 200-day moving average of $36.03.4. Applied Materials, Inc.
21.6% sales growth and 38.52% return on equity
Applied Materials, Inc. provides manufacturing equipment, services, and software to the semiconductor, display, and related industries.
Applied Materials, Inc.'s sales growth this year is anticipated to be 13.6% and 5% for next year.
Year-on-year quarterly revenue growth grew by 24.9%, now sitting on 17.2B for the twelve trailing months.
Applied Materials, Inc.'s sales growth for the next quarter is 21.6%. The company's growth estimates for the current quarter and the next is 28.6% and 36%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 38.52%.
Volatility
Applied Materials, Inc.'s last day, last week, and last month's average volatility was a negative 0.79%, a positive 0.55%, and a positive 0.12%, respectively.
Applied Materials, Inc.'s last day, last week, and last month's high and low average amplitude percentage was 2.22%, 2.19%, and 2.38%, respectively.
Applied Materials, Inc.'s Stock Yearly Top and Bottom Value
Applied Materials, Inc.'s stock is valued at $86.30 at 19:22 EST, below its 52-week high of $90.61 and way higher than its 52-week low of $36.64.
Applied Materials, Inc.'s Moving Average
Applied Materials, Inc.'s value is higher than its 50-day moving average of $83.12 and way higher than its 200-day moving average of $67.01.5. NVIDIA
50% sales growth and 28.82% return on equity
NVIDIA Corporation operates as a visual computing company worldwide.
NVIDIA's sales growth this year is anticipated to be 51% and 20.5% for next year.
Year-on-year quarterly revenue growth grew by 56.8%, now sitting on 14.78B for the twelve trailing months.
NVIDIA's sales growth for the next quarter is 50%. The company's growth estimates for the current quarter and the next is 48.1% and 40%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 28.82%.
Volatility
NVIDIA's last day, last week, and last month's average volatility was a negative 0.70%, a positive 0.07%, and a negative 0.12%, respectively.
NVIDIA's last day, last week, and last month's high and low average amplitude percentage was 1.83%, 1.98%, and 2.20%, respectively.
NVIDIA's Stock Yearly Top and Bottom Value
NVIDIA's stock is valued at $522.20 at 19:22 EST, way under its 52-week high of $589.07 and way higher than its 52-week low of $180.68.